<unk>  is a cholinesterase inhibitor that is FDA approved for the treatment of myasthenia gravis.   Common adverse reactions include excessive salivation, abdominal cramps, diarrhea, miosis, urinary urgency, sweating, nausea, increase in bronchial and lachrymal secretions, vomiting, anxiety, vertigo, bradycardia and cardiac conduction disorders.
Ambenonium
Meldonium
Edrophonium
Oogonium
Benzethonium chloride
Isavuconazonium
Suxamethonium chloride
Dimethyltubocurarine